Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Zinc finger protein 493 is a human protein belonging to the zinc finger family, specifically classified within the C2H2-type Krueppel family of transcription factors. It is predicted to enable DNA binding and zinc ion binding activity and may be involved in the regulation of transcription by RNA polymerase II, functioning as a sequence-specific transcription activator. Like other zinc finger proteins, ZNF493 likely uses zinc finger motifs to interact with nucleic acids, most commonly DNA, but its specific targets and biological roles remain incompletely characterized. There is no evidence to date linking ZNF493 directly to any human disease or to therapeutic targeting.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zinc finger protein 493 (ZNF493).